Articles

Results 1 to 5 of 9
Most popular |Most recent


Anticompetitive unilateral conduct in the pharmaceutical sector in USA

USA - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in USA, including IP rights abuse and pricing conduct....

Thomas J. Miller, Nicholas Passaro, Mike Cowie.

Anticompetitive agreements in the pharmaceutical sector in USA

USA - September 6 2019 An overview of essential considerations surrounding anticompetitive agreements in the pharmaceutical sector in USA, including the assessment framework and special issues with vertical agreements....

Thomas J. Miller, Nicholas Passaro, Mike Cowie.

Pharmaceutical antitrust law in USA

USA - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in USA, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance....

Thomas J. Miller, Nicholas Passaro, Mike Cowie.

D.C. Circuit Affirms Denial of Class Certification; Plaintiffs Derailed by Expert Model Showing Uninjured Shippers

USA - August 20 2019 On August 16, 2019, the D.C. Circuit Court of Appeals affirmed a denial of class certification to a proposed class of shippers see...

Thomas J. Miller, Shari Ross Lahlou, Steven E. Bizar.

The Third Circuit Clips the Federal Trade Commission’s Wings in FTC v. Shire ViroPharma

USA - March 4 2019 On February 25, 2019, the Third Circuit held that the Federal Trade Commission cannot bring litigation in federal court based on past conduct, absent...

Thomas J. Miller.